DBV Technologies (DBVT) Treasury Shares (2018 - 2026)
DBV Technologies (DBVT) posted quarterly Treasury Shares of $800000.0 for Q2 2026, down 35.38% year-on-year from $1.2 million in Q2 2025, and down 20.0% on a QoQ basis from $1.0 million in Q1 2026.
DBV Technologies (DBVT) Treasury Shares (2018 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Treasury Shares for 8 consecutive years, with $800000.0 the latest figure, recorded in Q2 2026.
- Quarterly Treasury Shares fell 35.38% year-over-year to $800000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $800000.0 (down 35.38% YoY) and the FY2025 annual result came in at $800000.0, down 38.88% from the prior year.
- Treasury Shares eased to $800000.0 in Q2 2026 per DBVT's latest filing, from $1.0 million in the prior quarter.
- Over the last five years, Treasury Shares for DBVT reached as high as $9.9 million in Q2 2026 and fell as low as $266868.0 in Q4 2024.
- A 5-year average of $2.4 million and a median of $2.0 million in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares soared 75.18% — and 2025, when it slumped 38.88%.
- Year by year, Treasury Shares stood at $1.1 million in 2022, then climbed by 13.89% to $1.3 million in 2023, then rose by 3.64% to $1.3 million in 2024, then tumbled by 38.88% to $800000.0 in 2025, then changed by 0.0% to $800000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $800000.0, $1.0 million, and $800000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 9.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.92 Mn |
| Jun 30, 2026 | 800,000.00 |
| Jun 30, 2026 | 800,000.00 |
| Jun 30, 2026 | 9.92 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 1.12 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 1.24 Mn |